M. Hazebroek

发表

Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias

S. Heymans, H. Brunner, V. V. van Empel, 2018, European heart journal.

Biomarker‐based assessment of collagen cross‐linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

S. Heymans, J. Staessen, F. Zannad, 2021, European journal of heart failure.

Delivery of Low-Volume Road in Pilbara Region of Western Australia by Alliance Contracting

Robert Wilson, M. Hazebroek, T. Pearce, 2011 .

Prognostic Relevance of Gene-Environment Interactions in Patients With Dilated Cardiomyopathy: Applying the MOGE(S) Classification.

S. Heymans, H. Crijns, H. Brunner-La Rocca, 2015, Journal of the American College of Cardiology.

Virus Infection of the Heart – Unmet Therapeutic Needs

S. Heymans, M. Hazebroek, R. Dennert, 2012, Antiviral chemistry & chemotherapy.

Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure.

A. Mebazaa, J. Leenders, S. Heymans, 2019, Circulation. Heart failure.

Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature

S. Heymans, H. Brunner-La Rocca, Y. Debing, 2016, European journal of heart failure.

Cardiac Inflammation Impedes Response to Cardiac Resynchronization Therapy in Patients with Idiopathic Dilated Cardiomyopathy.

S. Heymans, K. Vernooy, H. Brunner, 2020, Circulation. Arrhythmia and electrophysiology.

Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review

W. Paulus, S. Heymans, R. D. de Boer, 2020, European journal of heart failure.

Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.

S. Heymans, F. T. ten Cate, C. D. dos Remedios, 2013, Cardiovascular research.

The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial

S. Heymans, J. Staessen, J. Cleland, 2020, European heart journal.

Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in Dilated Cardiomyopathy.

S. Heymans, C. Knackstedt, R. Nijveldt, 2022, JACC. Cardiovascular imaging.

Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data

D. O’Regan, D. Pennell, S. Heymans, 2022, Journal of the American College of Cardiology.

Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.

S. Heymans, M. Schalij, K. Zeppenfeld, 2015, Heart rhythm.

Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study

J. De Sutter, R. Tieleman, P. Woudstra, 2021, BMC Geriatrics.

Immunosuppressive Therapy Improves Both Short- and Long-Term Prognosis in Patients With Virus-Negative Nonfulminant Inflammatory Cardiomyopathy

S. Heymans, P. van Paassen, V. V. van Empel, 2018, Circulation. Heart failure.

Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy

S. Heymans, H. Brunner, H. Brunner-La Rocca, 2018, Circulation. Heart failure.

Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial

S. Heymans, J. Staessen, F. Zannad, 2022, European journal of heart failure.

Value of Speckle Tracking-Based Deformation Analysis in Screening Relatives of Patients Asymptomatic Dilated Cardiomyopathy.

S. Heymans, J. Lumens, H. Brunner, 2020, JACC. Cardiovascular imaging.

Diagnostic approach of myocarditis: strike the golden mean

S. Heymans, M. Hazebroek, K. Everaerts, 2014, Netherlands Heart Journal.

The effect of spironolactone in patients with obesity at risk for heart failure: proteomic insights from the HOMAGE trial

S. Heymans, F. Zannad, J. Cleland, 2021, Journal of Cardiac Failure.

Prevalence of Pathogenic Gene Mutations and Prognosis Do Not Differ in Isolated Left Ventricular Dysfunction Compared With Dilated Cardiomyopathy

S. Heymans, H. Brunner, H. Brunner-La Rocca, 2018, Circulation. Heart failure.

Myocardial Fibrosis Assessment Using T1 and ECV Mapping With Histologic Validation in Chronic Dilated Cardiomyopathy.

J. Wildberger, V. V. van Empel, H. Brunner-La Rocca, 2022, JACC. Cardiovascular imaging.

Implications of Genetic Testing in Dilated Cardiomyopathy

S. Heymans, H. Brunner, J. Verdonschot, 2020, Circulation. Genomic and precision medicine.

Idiopathic dilated cardiomyopathy: possible triggers and treatment strategies

S. Heymans, M. Hazebroek, R. Dennert, 2012, Netherlands Heart Journal.

Dyskalemia in people at increased risk for heart failure: findings from the heart ‘OMics’ in AGEing (HOMAGE) trial

S. Heymans, J. Staessen, J. Cleland, 2022, ESC heart failure.

The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles

S. Heymans, H. D. den Ruijter, V. V. van Empel, 2022, ESC heart failure.

Should we still monitor QTc duration in frail older patients on low-dose haloperidol? A prospective observational cohort study.

F. Prinzen, P. Bordachar, S. Ploux, 2020, Age and ageing.

Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy

D. Pennell, S. Heymans, S. Cook, 2022, Circulation.

Mutations in PDLIM5 are rare in dilated cardiomyopathy but are emerging as potential disease modifiers

Kiely N. James, S. Heymans, H. Brunner, 2019, Molecular genetics & genomic medicine.

The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial

S. Heymans, J. Staessen, F. Zannad, 2022, European journal of heart failure.

Metabolic Profiling Associates with Disease Severity in Non-Ischemic Dilated Cardiomyopathy.

S. Heymans, H. Brunner, J. Bierau, 2020, Journal of cardiac failure.

Interatrial Block Predicts Life‐Threatening Arrhythmias in Dilated Cardiomyopathy

S. Heymans, K. Vernooy, A. Bayés‐Genís, 2022, Journal of the American Heart Association.

A passionate endurance cyclist ultimately survives sudden death in right ventricular giant cell myocarditis.

J. Maessen, S. Heymans, L. Cooper, 2014, International journal of cardiology.

Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial

S. Heymans, J. Staessen, F. Zannad, 2022, Clinical Research in Cardiology.

The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis.

B. Schroen, R. V. van Leeuwen, S. Heymans, 2015, European heart journal.

ANCA-Associated Vasculitis: Microscopic Polyangiitis, Eosinophilic Granulomatosis With Polyangiitis (Churg–Strauss Syndrome) and Granulomatosis With Polyangiitis (Wegener’s Granulomatosis)

S. Heymans, M. Hazebroek, P. Paassen, 2017 .

MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis

Stephane Heymans, Georg Summer, Peter Carmeliet, 2012, Circulation research.

Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.

S. Heymans, J. Staessen, T. Kuznetsova, 2015, International journal of cardiology.

Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach

S. Heymans, J. Ware, S. Prasad, 2019, Journal of the American Heart Association.

Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial

S. Heymans, P. van Paassen, V. V. van Empel, 2020, European journal of heart failure.

Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF.

S. Heymans, J. Staessen, F. Zannad, 2020, JACC. Heart failure.

Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients

S. Heymans, C. Knackstedt, G. Sinagra, 2022, Journal of the American Heart Association.

Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial.

S. Heymans, J. Staessen, L. Thijs, 2021, European heart journal. Cardiovascular pharmacotherapy.

Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmias

S. Heymans, G. Barbati, L. Potena, 2021, European Journal of Heart Failure.

Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences

S. Heymans, H. Brunner, F. Domínguez, 2020, European heart journal.

S. Heymans, P. van Paassen, V. V. van Empel, 2021, European Journal of Heart Failure.

Identification of sex‐specific biomarkers predicting new‐onset heart failure

S. Heymans, J. Staessen, R. D. de Boer, 2021, ESC heart failure.

Macrophage MicroRNA-155 Promotes Cardiac Hypertrophy and Failure

M. Giacca, M. Mayr, B. Schroen, 2013, Circulation.

Propionic acidemia as a cause of adult-onset dilated cardiomyopathy

S. Heymans, H. Brunner, S. Ferdinandusse, 2017, European Journal of Human Genetics.

Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

A. Mebazaa, Daniel Levy, S. Heymans, 2023, Circulation. Heart failure.

Heart Failure With Recovered Ejection Fraction.

S. Heymans, J. Lumens, H. Brunner-La Rocca, 2018, Journal of the American College of Cardiology.

Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry

R. V. van Leeuwen, S. Heymans, K. Vernooy, 2022, ESC heart failure.

Left Atrial Function in Patients with Titin Cardiomyopathy.

J. Lumens, K. Vernooy, H. Brunner, 2023, Journal of cardiac failure.

The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy

S. Heymans, H. Brunner, V. V. van Empel, 2021, European Journal of Heart Failure.

S. Heymans, H. Brunner, V. V. van Empel, 2021, European journal of heart failure.

Distinct Cardiac Transcriptomic Clustering in Titin and Lamin A/C-Associated Dilated Cardiomyopathy Patients.

S. Heymans, H. Brunner, M. Adriaens, 2020, Circulation.

Cardiac Inflammation in Adult-Onset Genetic Dilated Cardiomyopathy

S. Heymans, J. Verdonschot, M. Hazebroek, 2023, Journal of clinical medicine.

Dynamic Ejection Fraction Trajectory in Patients With Dilated Cardiomyopathy With a Truncating Titin Variant.

S. Heymans, H. Brunner, C. Knackstedt, 2022, Circulation. Heart failure.

Chronic Q fever leads to dilated cardiomyopathy in a 48-year-old male.

S. Heymans, M. Hazebroek, J. Merken, 2016, International journal of cardiology.

Heart Failure With Recovered Ejection Fraction.

S. Heymans, J. Lumens, H. Brunner-La Rocca, 2018, Journal of the American College of Cardiology.

Biomarkers of Collagen Metabolism Are Associated with Left Ventricular Function and Prognosis in Dilated Cardiomyopathy: A Multi-Modal Study

V. V. van Empel, H. Brunner-La Rocca, C. Knackstedt, 2023, Journal of clinical medicine.

The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis.

B. Schroen, R. V. van Leeuwen, S. Heymans, 2015, European heart journal.

Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial

F. Zannad, B. Pieske, P. Rossignol, 2023, ESC heart failure.

One step closer to the new frontiers of healthcare for cardiomyopathy patients

J. Verdonschot, M. Hazebroek, 2023, Heart.